Global Dental Implants Market: Overview
This report on dental implants studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various dental implants and products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global dental implants market with respect to the leading market segments based on major products, key materials utilized, end-users, and geographies.
This 186 page report gives readers a comprehensive overview of the dental implants market. Browse through 38 data tables and 59 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/dental-implants-market.html
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global dental implants market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/materials/end-users/geographies. The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes completion matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.
Global Dental Implants Market: Segment Analysis
The global dental implants market has been studied based on major implantable product segments, material segments, their end-users, and regional as well as national markets. Based on product type, the global market has been categorized into three major 4 segments: Endosteal Implants, Subperiosteal Implants, Transosteal Implants, and Intramucosal Implants.
Based on material, the global market has been categorized into five major segments Titanium Implants Zirconium Implants, Based on end-user market has been categorized as Hospitals, Dental Clinics, Academic & Research Institute, Others. The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2016 as the base year.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving dental implants market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=224
Global Dental Implants Market: Regional Analysis
Geographically, the dental implants market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for dental Implants has been further categorized into major product, material, and end-user segments considered within the scope of the study. Key country (U.S., Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn and volume in terms of units for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2016 as the base year.
The report also profiles key players operating in the dental implants market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include Danaher Corporation, Dentsply Sirona, Institut Straumann AG, and Zimmer Biomet Holdings, 3M Health Care, CAMLOG Biotechnologies AG etc
In the last few years, the incidence of chronic illnesses has considerably increased among women. Be it the change in lifestyle or the rising geriatric populations, experts project this prevalence to continue rising in the forthcoming years as well, thus making women health rehabilitation more imperative than ever. Medical rehabilitation is a highly monitored activity considered indispensable for assisting in the improvement overall health status after a prolonged illness. Demand for women rehabilitation has therefore substantially increased in the recent years. The increasing maternal deaths, especially in developing nations, rising injuries due to road accidents, and the increasing prevalence cardiovascular ailments causing death of women have compelled governments to focus more on women health and rehabilitation.
Transparency Market Research (TMR) forecasts the global women health rehabilitation products market to reach US$4.2 bn by the end of 2024, from a valuation of US$2.6 bn in 2015. The market is therefore expected to rise at a CAGR of 5.0% between 2016 and 2024.
This 111 page report gives readers a comprehensive overview of the women health rehabilitation products market. Browse through 8 data tables and 22 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/womens-health-rehabilitation-products-market.html
Rehabilitation has emerged as an important method of mitigating the burgeoning risk of chronic diseases among women. These services are designed to improve the overall heart health, increase metabolism, expedite faster recovery, and improve hormonal profile among ailing women. Their demand has thus increased in response to the drastically changing lifestyle and dietary preferences. Integration of advanced technologies in existing rehabilitation products has further boosted prospects for their sales.
Earlier, acceptance of health rehabilitation services was a major issue across developed nations, which is now resolved with the rising awareness. However high product pricing still creates major bottlenecks for the sales of health rehabilitation products in emerging economies.
North America, Trailed by Europe, Emerged Key Contributors in 2015
Regionally, North America emerged as the key contributor in the global health rehabilitation products market in 2015, trailed by Europe. The market in North America is expected to reach US$1.5 bn by the end of 2024, from US$1 bn in 2015, rising at a CAGR of 4.9% during the period. High demand for women health rehabilitation products in both Europe and North America is attributed to the increasing number of road accidents in the last few years and the rising geriatric population. However, TMR projects Asia Pacific to exhibit the fastest CAGR due to the presence of untapped opportunities in the region. Besides this, Asia Pacific boasts a developing health care infrastructure and strong presence of skilled health care professionals, which is expected to drive demand for women health rehabilitation products in the region.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving women health rehabilitation products market during 2016 – 2024: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13022
Rising Geriatric Population Boosts Demand for Treat Urinary Incontinence Products
By product type, orthopedic, pelvic pain product, urinary incontinence, pregnancy and postpartum, lymphedema, breast cancer, and osteoporosis constitute the major segments in the global women health rehabilitation products market. Of these, urinary incontinence held the dominant share in the market in 2015. It is also projected to maintain its lead through the forecast period. Increasing urinary incontinence among aged women is expected to keep demand from this segment high in the forthcoming years. The segment is expected to report a CAGR of 5.4% during the forecast period.
Some of the leading players operating in the global women health rehabilitation products market include Access Health (Victoria, Australia), Carib Rehab Ltd. (St. Michael, Barbados), GE Healthcare (Chalfont St. Giles, U.K.), GPC Medical Ltd.( New Delhi, India), Pelvic Health and Rehabilitation (San Francisco, U.S.), Rehab Plus (Timmins, Canada), Meyer Physical Therapy (New York, U.S.), Sportstek (Oakleigh, Australia), Vandana Surgical Cotton Ind. (Ajmer, India), and Win Health Medical Ltd. (Jedburgh, U.K.)
Medical Automation Market: Overview
In a highly competitive pharmaceutical industry, automation can prove to be a massive operational advantage and a key differentiator for players of all sizes. The future of the healthcare industry is increasingly being defined by the advent of faster, more accurate, and easy-to-use devices that are riding high on the wave of medical automation. With a massive number of people crossing the 60-year threshold, the healthcare industry is facing a pressing need to scale up resources and brace for a spike in healthcare needs. This is where automation is expected to be the real game changer.
There are several market dynamics that are collectively creating a need for more automation in the medical industry. According to an article published in Health Affairs, there will be a shortage of 260,000 registered nurses by 2025 in the U.S. The scenario won’t be drastically different in other developed countries where the workforce is aging rapidly. With fewer humans available to carry out all of the tasks in the healthcare industry, healthcare institutions and pharmaceutical companies are focusing on automation to get redundant and repetitive tasks done. However, as has been the case with several other industries, automation is regarded as a job killer and has been opposed in several countries worldwide.
These push and pull factors will decide how this market shapes up in the coming years. This is what the report aims to assess. The report creates segments of the global medical automation market based on criteria such as applications, end-users, and geography.
Obtain Report Details: http://www.transparencymarketresearch.com/medical-automation-market.html
Global Medical Automation Market: Drivers and Restraints
Companies and medical institutions are channeling more funds into medical automation systems and software enticed by benefits such as cost containment, increased speed, greater transparency in processing, and reduction in errors. This thus lays a strong foundation for the growth of the global medical automation market. Another change that is driving the adoption of medical automation is the high degree of interest in point-of-care testing devices for pregnancy, blood glucose levels, blood pressure, and HIV.
On the flip side, the lack of widespread standardization and a heterogeneous regulatory environment will create several obstacles for companies operating in the medical automation market. Moreover, not all healthcare institutions can afford medical automation. It will be a few years before developing countries wholly embrace this trend.
The top trends that are shaping the global medical automation market are affordable automation software and systems that make everyday tasks easier. There is a massive market that hitherto remains untapped in emerging countries, where the healthcare sector is heaving under the burden of obsolete machinery and techniques. This gap could provide a window of opportunity for companies offering medical automation software and solutions.
Global Medical Automation Market: Drivers and Restraints
The global market for medical automation can be segmented broadly based on the following fronts: End user, application, and geography. The key application areas of medical automation are therapeutic automation, lab automation, pharmacy automation, and medical automation. The segment of medical automation is composed of automated imaging and analysis and point of care testing market. The market for therapeutic automation can similarly be split into surgical and non-surgical automation. Each of these sub-segments can be further segmented based on the automation devices.
Likewise, the market for lab automation can be classified into liquid handling, automated storage systems, robots and informatics, and microplate readers. The market for pharmacy automation can be further split into automated dispensaries, automated pharmaceutical packaging, and automated/smart medication compounding. The key end users in the global medical automation market are: Research labs, pharmacies, hospital and diagnostic centers, and home care centers.
Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11921
Using geography as a criteria, the global medical automation market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. The market for medical automation is currently the largest in North America. It is also well-established in Europe. The rising demand for medical automation solutions and software in Asian countries such as Taiwan and China will be a crucial turning point for the market.
Companies that are currently at the forefront of the global medical automation market are: Carefusion Corp, Medtronic, Inc., GE Healthcare, Intuitive Surgical Inc., Roche Holding AG, Omnicell, Inc, Siemens Healthcare, Philips Healthcare, Stryker Corporation, St. Jude Medical, Inc., and others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The global image guided surgery devices market is progressing at a CAGR of 6.40% within a forecast period from 2014 to 2022. The market’s value in 2013 was US$2.7 bn and is expected to grow to US$4.8 bn by the end of 2022, as given in a market research report released by Transparency Market Research. The report, titled “Image Guided Surgery Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 -2022”, provides extensive details on the market for the given forecast period.
Details in the report reveal the primary driver of the global image guided surgery devices market to be the advantages provided by the surgical procedure itself. These include a drastic reduction in the time of surgery, reduction in surgery scars, and a rapid post-surgery healing rate. The market is also backed by the growing number of incidents of physical trauma, neural diseases, and orthopedic issues that require surgical intervention.
This 144 page report gives readers a comprehensive overview of the Image Guided Surgery Devices Market. Browse through 38 data tables and 49 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/image-guided-surgery.html
Based on application, the global image guided surgery devices market was dominated by the neurosurgery applications segment in 2013. The segment led the global image guided surgery devices market owing to the minimal risk of damage caused to non-surgical brain sites and a greatly heightened level of operating accuracy. The orthopedic surgery application segment, on the other hand, is expected to expand at a 7.0% CAGR between 2014 and 2022, which is the fastest growth rate among the applications segments. This segment is growing due to an increasing geriatric population.
According to device type, the global image guided surgery devices market was largely dominated by the computed tomography segment. CT-guided surgeries are touted to have the highest level of accuracy, along with a turnaround time of less than 500 milliseconds. The CT scanner segment in 2013 was valued at US$770 mn.The global image guided surgery devices market is expected to grow at a faster pace due to a growing number of accidents. Cited in the report is a statement by the ASIRT, which reveals that there are between 20 mn to 50 mn people who are injured or even disabled every year in road accidents.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Image Guided Surgery Devices Market during 2014 – 2022:
The largest regional segment of the global image guided surgery devices market for 2013 was North America, closely followed by Europe, owing to the high level of expenditure on healthcare, feasible reimbursement schemes, rapid advancement of technology and its adoption, and the availability of skilled professionals.The Asia Pacific image guided surgery devices market is expected to progress at a 6.90% CAGR between 2014 and 2022, owing to a growing scope of medical tourism and improvements in healthcare infrastructure.
The key players in the global image guided surgery devices market are Medtronic, Inc., Stryker, St. Jude Medical, Inc., Smith & Nephew plc, Zimmer Holdings, Inc., Siemens AG, Toshiba Corp., Karl Storz GmbH & Co. KG., Integra LifeSciences Corp., IMRIS, Inc., GSI Group, Inc., General Electric Company, Brainlab AG, and Analogic Corp.
Asia Pacific Platelet Rich Plasma Market Trends, Regulatory Landscape and Operational Strategies 2023
The platelet rich plasma market in Asia Pacific represents a semi-consolidated competitive landscape. According to a new study by Transparency Market Research (TMR), the top five companies in the market, including Harvest Technologies, Arthrex, Inc., Zimmer Biomet, DePuy Synthes, and Stryker accounted for approximately 79% of the Asia Pacific platelet rich plasma market in 2014. Of these, Harvest Technology, a subsidiary of Terumo Corporation led the Asia Pacific PRP market in 2014, holding a share of over 25%.
Enterprises Engaged in Sales of PRP devices Gain from Rising Medical Tourism in Asia Pacific
The recent advances in PRP devices owing to the increasing research and development activities have bolstered the demand for PRP therapy. Additionally, the rising prevalence of orthopedic diseases, sports injuries, neurological disorders, obesity, and cardiovascular diseases has been boosting the Asia Pacific platelet rich plasma market. “With millions opting for cosmetic surgeries globally, prospects for growth of the Asia Pacific PRP market seem quite impressive in the forthcoming years,” said a lead analyst at TMR.
This 128 page report gives readers a comprehensive overview of the Asia Pacific Platelet Rich Plasma Market: http://www.transparencymarketresearch.com/asia-pacific-platelet-rich-plasma-market.html
In the last few years, Asia Pacific has emerged at the fore of the medical tourism industry. The region has witnessed rapid advancements in healthcare, which have catapulted it as a major destination for cosmetic surgeries at affordable price. The TMR analyst says, “With millions of people exploring options for non-invasive cosmetic surgeries, medical tourism is expected to surge in Asia Pacific, thus boosting demand for PRP from the region.” Besides this, the widespread use of platelet rich plasma is also expected to accelerate growth of the market.
Among other drivers, the rising awareness about PRP devices across emerging nations will boost PRP sales in Asia Pacific. However, the rapid commercialization of treatments has increased prices of PRP. This has emerged as a major bottleneck hindering growth of the platelet rich plasma market in Asia Pacific. Furthermore, increasing awareness regarding threats commonly associated with the use of PRP also limits the PRP sales to an extent.
Nevertheless, with the advent of novel applications of PRP technologies, leading enterprises offering PRP products and devices will witness new opportunities to capitalize on. These companies are also expected to considerably gain from the evolution of the latest devices.
China and Australia Emerge as Most Lucrative Markets for PRP in Asia Pacific
Regionally, China and Australia have emerged as the most lucrative markets for platelet rich plasma products and devices in Asia Pacific. Both these regions boast a well-established healthcare infrastructure. This, combined with the increasing investment in research and development and high awareness pertaining to uses of PRP, will accelerate PRP sales in Asia Pacific.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Asia Pacific Platelet Rich Plasma Market during 2015 – 2023 http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8707
China presently accounts for the leading share in the Asia Pacific platelet rich plasma market, followed by Australia and South Korea, in that order. India currently holds only a small share in the market. However, in the next few years, PRP demand from the country is likely to increase at a robust pace. The increasing geriatric population and presence of many skilled doctors in the country will augment demand for PRP in India.
Rise in Orthopedic Surgeries to Boost Demand for PRP
By application, orthopedic surgeries accounted for the highest demand for platelet rich plasma in Asia Pacific. Demand for PRP in the cosmetic surgeries is also expected to increase rapidly in the forthcoming years. Furthermore, the Asia Pacific market for PRP is also expected to significantly gain from the increasing use of platelet rich plasma as a substitute of derma fillers.
Transparency Market Research has pegged the overall value of the Asia Pacific platelet rich plasma market to reach US$110.0 mn by the end of 2023. The market stood at US$30 mn in 2014 and is expected to rise at an impressive CAGR of 15.4% between 2015 and 2023.
The review is based on information published by Transparency Market Research in a report, titled “Platelet Rich Plasma Market – Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023.”